(Q33882609)

29 July 2017

title

How an inhibitor of the HIV-I protease modulates proteasome activity (English)

1 reference

29 July 2017

author

Hermann-Georg Holzhütter

2

object named as

Holzhütter HG

1 reference

29 July 2017

Schmidtke G

1

1 reference

29 July 2017

Bogyo M

3

1 reference

29 July 2017

Kairies N

4

1 reference

29 July 2017

Groll M

5

1 reference

29 July 2017

de Giuli R

6

1 reference

29 July 2017

Emch S

7

1 reference

29 July 2017

Groettrup M

8

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 December 1999

1 reference

Journal of Biological Chemistry

29 July 2017

published in

1 reference

29 July 2017

volume

274

1 reference

29 July 2017

issue

50

1 reference

29 July 2017

page(s)

35734-35740

1 reference

Current knowledge and future prospects for the use of HIV protease inhibitors

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.50.35734

Design, activity, and 2.8 A crystal structure of a C2 symmetric inhibitor complexed to HIV-1 protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.50.35734

Structure and functions of the 20S and 26S proteasomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.50.35734

The interferon-gamma-inducible 11 S regulator (PA28) and the LMP2/LMP7 subunits govern the peptide production by the 20 S proteasome in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.50.35734

Cleavage motifs of the yeast 20S proteasome beta subunits deduced from digests of enolase 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.50.35734

Contribution of proteasomal beta-subunits to the cleavage of peptide substrates analyzed with yeast mutants

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.50.35734

HIV-1 protease inhibitors. A review for clinicians

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.50.35734

HIV treatment failure: testing for HIV resistance in clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.50.35734

ABT-538 is a potent inhibitor of human immunodeficiency virus protease and has high oral bioavailability in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.50.35734

An inhibitor of HIV-1 protease modulates proteasome activity, antigen presentation, and T cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.50.35734

Peptide antigen production by the proteasome: complexity provides efficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.50.35734

Using ubiquitin to follow the metabolic fate of a protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.50.35734

Inactivation of a defined active site in the mouse 20S proteasome complex enhances major histocompatibility complex class I antigen presentation of a murine cytomegalovirus protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.50.35734

Substrate binding and sequence preference of the proteasome revealed by active-site-directed affinity probes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.50.35734

A fast flexible docking method using an incremental construction algorithm.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.50.35734

Structure of 20S proteasome from yeast at 2.4 A resolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.50.35734

A fast and efficient method to generate biologically relevant conformations

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.50.35734

Multiple automatic base selection: protein-ligand docking based on incremental construction without manual intervention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.50.35734

Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.50.35734

In vivo inhibition of cyclin B degradation and induction of cell-cycle arrest in mammalian cells by the neutral cysteine protease inhibitor N-acetylleucylleucylnorleucinal

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.50.35734

Covalent modification of the active site threonine of proteasomal beta subunits and the Escherichia coli homolog HslV by a new class of inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.50.35734

The active sites of the eukaryotic 20 S proteasome and their involvement in subunit precursor processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.50.35734

Mutational analysis of subunit i beta2 (MECL-1) demonstrates conservation of cleavage specificity between yeast and mammalian proteasomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.50.35734

Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.50.35734

A beta-lactone related to lactacystin induces neurite outgrowth in a neuroblastoma cell line and inhibits cell cycle progression in an osteosarcoma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.50.35734

Interferon-gamma can stimulate post-proteasomal trimming of the N terminus of an antigenic peptide by inducing leucine aminopeptidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.50.35734

21 January 2018

Identifiers

DOI

10.1074/JBC.274.50.35734

1 reference

29 July 2017

1 reference